Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Peripheral Arterial Occlusive Disease · Critical Limb Ischemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University Medical Center Groningen, Groningen, Netherlands
Contact: Study coordinator (Anne-Fleur Verhaar, MD)

Study leads

Schelto Kruijff, MD, Prof
Principal Investigator
University Medical Center Groningen, NL

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

Stable Coronary Artery Disease · Acute Coronary Syndromes · Critical Limb Ischemia

Abroad (travel likely)Recruiting

Cotignola, Italy

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

Critical Limb Ischemia (CLI)

Abroad (travel likely)Recruiting

Graz, Austria

Serrantor OCT Study

Critical Limb Ischemia

Abroad (travel likely)Recruiting

New York, United States · New York, United States

miRNAs in Critical Limb Ischemia (miRNACLI)

Critical Limb Ischemia

Abroad (travel likely)Recruiting

San Donato Milanese, Italy